These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

379 related items for PubMed ID: 26452314

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Angiogenesis markers in breast cancer--potentially useful tools for priority setting of anti-angiogenic agents.
    Keyhani E, Muhammadnejad A, Behjati F, Sirati F, Khodadadi F, Karimlou M, Moghaddam FA, Pazhoomand R.
    Asian Pac J Cancer Prev; 2013; 14(12):7651-6. PubMed ID: 24460348
    [Abstract] [Full Text] [Related]

  • 3. Expression of Bax and Bcl-2 in tumour cells and blood vessels of breast cancer and their association with angiogenesis and hormonal receptors.
    Jaafar H, Abdullah S, Murtey MD, Idris FM.
    Asian Pac J Cancer Prev; 2012; 13(8):3857-62. PubMed ID: 23098483
    [Abstract] [Full Text] [Related]

  • 4. Elevated Interleukin-13 Receptor Alpha 1 Expression in Tumor Cells Is Associated with Poor Prognosis in Patients with Invasive Breast Cancer.
    Park MH, Kwon HJ, Kim JR, Lee B, Lee SJ, Bae YK.
    Ann Surg Oncol; 2017 Nov; 24(12):3780-3787. PubMed ID: 28634667
    [Abstract] [Full Text] [Related]

  • 5. Microvessel density, VEGF expression, and tumor-associated macrophages in breast tumors: correlations with prognostic parameters.
    Bolat F, Kayaselcuk F, Nursal TZ, Yagmurdur MC, Bal N, Demirhan B.
    J Exp Clin Cancer Res; 2006 Sep; 25(3):365-72. PubMed ID: 17167977
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Characteristics of invasive breast ductal carcinoma, NOS, diagnosed in a tertiary institution in the East Coast of Malaysia with a focus on tumor angiogenesis.
    Ch'ng ES, Tuan Sharif SE, Jaafar H.
    Asian Pac J Cancer Prev; 2012 Sep; 13(9):4445-52. PubMed ID: 23167359
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Ki-67 is a prognostic marker for hormone receptor positive tumors.
    Pérez-López ME, García-Gómez J, Alves MT, Paradela A, García-Mata J, García-Caballero T.
    Clin Transl Oncol; 2016 Oct; 18(10):996-1002. PubMed ID: 26742937
    [Abstract] [Full Text] [Related]

  • 10. Markers of progression and invasion in short term follow up of untreated breast cancer patients.
    Rabi ZA, Todorović-Raković N, Vujasinović T, Milovanović J, Nikolić-Vukosavljević D.
    Cancer Biomark; 2015 Oct; 15(6):745-54. PubMed ID: 26406416
    [Abstract] [Full Text] [Related]

  • 11. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
    Kurebayashi J, Kanomata N, Yamashita T, Shimo T, Mizutoh A, Moriya T, Sonoo H.
    Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prognostic significance of geminin expression levels in Ki67-high subset of estrogen receptor-positive and HER2-negative breast cancers.
    Yagi T, Inoue N, Yanai A, Murase K, Imamura M, Miyagawa Y, Enomoto Y, Nishimukai A, Takatsuka Y, Hirota S, Akazawa K, Miyoshi Y.
    Breast Cancer; 2016 Mar; 23(2):224-30. PubMed ID: 25082658
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies.
    Eberhard A, Kahlert S, Goede V, Hemmerlein B, Plate KH, Augustin HG.
    Cancer Res; 2000 Mar 01; 60(5):1388-93. PubMed ID: 10728704
    [Abstract] [Full Text] [Related]

  • 20. Comparisons of p53, KI67 and BRCA1 expressions in patients with different molecular subtypes of breast cancer and their relationships with pathology and prognosis.
    Li Y, Zhang X, Qiu J, Pang T, Huang L, Zeng Q.
    J BUON; 2019 Mar 01; 24(6):2361-2368. PubMed ID: 31983107
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.